Price-Hiking Pharma Exec Martin Shkreli Gets House Subpoena

Martin Shkreli leaves the courthouse after his arraignment in New York, Dec. 17, 2015. AP Photo/Seth Wenig, File

WASHINGTON—House lawmakers have issued a subpoena to compel former Turing Pharmaceuticals CEO Martin Shkreli, reviled for price-gouging, to appear at a congressional hearing next Tuesday.

The House Committee on Oversight and Government Reform is investigating several companies for exorbitant drug price increases, including embattled Canadian drugmaker Valeant Pharmaceuticals.

Shkreli became notorious after his company Turing hiked the price of Daraprim, the only approved drug for a rare and sometimes deadly parasitic infection, by 5,000 percent. Since then, Shkreli has been deluged with criticism from patients, politicians and the media, with some labeling him the “most hated man in America.”

Shkreli became notorious after his company Turing hiked the price of Daraprim by 5,000 percent.